Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hengyi Petrochemical is a leading Chinese industrial conglomerate primarily focused on the petroleum refining and chemical fiber production sectors. The company operates an integrated "crude oil-PX-PTA-polyester" value chain and is one of the world's largest producers of purified terephthalic acid (PTA) and polyester yarn. Its primary business segments include the manufacturing of polyester yarn, chips, and fibers used extensively in the textile and packaging industries. While the company produces raw materials used in medical supplies such as surgical masks and protective clothing, it is not a biotechnology or pharmaceutical research entity. Headquartered in Hangzhou, it maintains significant international operations, including a major refinery and petrochemical complex in Brunei. Hengyi is publicly traded on the Shenzhen Stock Exchange and is a major player in the global petrochemical market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hengyi Petrochemical.